These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 34521025)

  • 1. Immune response variables and viral mutations impact on COVID-19 reinfection and relapse.
    Sanaie S; Golipour E; Shamekh A; Sadaie MR; Mahmoodpoor A; Yousefi M
    Int Immunopharmacol; 2021 Nov; 100():108108. PubMed ID: 34521025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
    Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
    Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    Rani PR; Imran M; Lakshmi JV; Jolly B; Jain A; Surekha A; Senthivel V; Chandrasekhar P; Divakar MK; Srinivasulu D; Bhoyar RC; Vanaja PR; Scaria V; Sivasubbu S
    J Med Virol; 2021 Jul; 93(7):4163-4165. PubMed ID: 33818797
    [No Abstract]   [Full Text] [Related]  

  • 5. Fast-spreading COVID variant can elude immune responses.
    Callaway E
    Nature; 2021 Jan; 589(7843):500-501. PubMed ID: 33479534
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies.
    Brehm TT; Pfefferle S; von Possel R; Kobbe R; Nörz D; Schmiedel S; Grundhoff A; Olearo F; Emmerich P; Robitaille A; Günther T; Braun P; Andersen G; Knobloch JK; Addo MM; Lohse AW; Aepfelbacher M; Fischer N; Schulze Zur Wiesch J; Lütgehetmann M
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33921216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.
    Kim YI; Kim SM; Park SJ; Kim EH; Yu KM; Chang JH; Kim EJ; Casel MAB; Rollon R; Jang SG; Um J; Song MS; Jeong HW; Kim EG; Kim Y; Kim SY; Park JS; Park MS; Kwon GY; Yeo SG; Lee SA; Choi YJ; Jung JU; Choi YK
    Emerg Microbes Infect; 2021 Dec; 10(1):152-160. PubMed ID: 33407005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity after recovery from SARS-CoV-2 infection.
    Kojima N; Klausner JD
    Lancet Infect Dis; 2022 Jan; 22(1):12-14. PubMed ID: 34762853
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.
    Borgogna C; De Andrea M; Griffante G; Lai A; Bergna A; Galli M; Zehender G; Castello L; Ravanini P; Cattrini C; Mennitto A; Gennari A; Gariglio M
    J Med Virol; 2021 Dec; 93(12):6444-6446. PubMed ID: 34260066
    [No Abstract]   [Full Text] [Related]  

  • 10. Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.
    Klein J; Brito AF; Trubin P; Lu P; Wong P; Alpert T; Peña-Hernández MA; Haynes W; Kamath K; Liu F; Vogels CBF; Fauver JR; Lucas C; Oh J; Mao T; Silva J; Wyllie AL; Muenker MC; Casanovas-Massana A; Moore AJ; Petrone ME; Kalinich CC; Dela Cruz C; Farhadian S; Ring A; Shon J; Ko AI; Grubaugh ND; Israelow B; Iwasaki A; Azar MM;
    J Infect Dis; 2022 Feb; 225(3):374-384. PubMed ID: 34718647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity.
    Yahav D; Yelin D; Eckerle I; Eberhardt CS; Wang J; Cao B; Kaiser L
    Clin Microbiol Infect; 2021 Mar; 27(3):315-318. PubMed ID: 33285276
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.
    Ibarrondo FJ; Hofmann C; Ali A; Ayoub P; Kohn DB; Yang OO
    mBio; 2021 Dec; 12(6):e0265621. PubMed ID: 34872349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea.
    Kim JM; Ryu B; Choe YJ; Jo HJ; Lee H; Kim HM; Lee NJ; Rhee JE; Chung YS; Han MG; Kim EJ; Park Y; Gwack J; Jin Y; Song J; Seo S; Gill B; Kim H; Park Y; Yoo CK; Jeong EK
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of protection from SARS-CoV-2 infection.
    Krammer F
    Lancet; 2021 Apr; 397(10283):1421-1423. PubMed ID: 33844964
    [No Abstract]   [Full Text] [Related]  

  • 16. Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection.
    Pérez-Lago L; Martínez-Lozano H; Pajares Díaz JA; Díaz Gómez A; Machado M; Sola-Campoy PJ; Herranz M; Buenestado-Serrano S; Valerio M; Olmedo M; Andrés Zayas C; Comas I; González Candelas F; Bañares R; Catalán P; Muñoz P; García de Viedma D
    J Infect Dis; 2021 Sep; 224(5):788-792. PubMed ID: 34107025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
    Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD
    Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay.
    Ahsan H; Sonn JK; Lee YS; Islam SU; Khalil SK
    Viral Immunol; 2021 Nov; 34(9):588-596. PubMed ID: 34101517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection.
    Yang G; Cao J; Qin J; Mei X; Deng S; Xia Y; Zhao J; Wang J; Luan T; Chen D; Huang P; Chen C; Sun X; Luo Q; Su J; Zhang Y; Zhong N; Wang Z
    Signal Transduct Target Ther; 2024 May; 9(1):141. PubMed ID: 38811527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.